JHS Svendgaard Laboratories Limited has informed the Exchange regarding Appointment of Mr Nikhil Nanda as Managing Director of the company w.e.f. July 02, 2025.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 0.9 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
JHS Svendgaard Laboratories has informed the stock exchanges about the re-appointment of Mr. Nikhil Nanda (DIN: 00051501) as the Managing Director of the company. His new term is effective from July 2, 2025, and runs for 5 years until the conclusion of the 26th Annual General Meeting in 2030. The appointment was approved by shareholders at a meeting held on September 20, 2025. Nanda is a first-generation entrepreneur with over 30 years of experience in the FMCG industry, a Business Management graduate from FORE School of Management, who founded the company in 1997 and took it public with a US$10 million IPO in 2006. He is not related to any existing Director or Key Managerial Personnel, and is not debarred by SEBI or any other authority from holding a director's position.
This is a re-appointment, not a new hire, so shareholders should view this as leadership continuity rather than a strategic change. A 5-year tenure provides stability, and the clean background disclosure (no SEBI debarment, no family ties to board) keeps governance concerns minimal.